Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 198

    1.

    The polycystic ovary unraveled.

    Gabrilove JL.

    Endocr Pract. 2009 Jul-Aug;15(4):386. No abstract available. PMID: 19454381 [PubMed - indexed for MEDLINE]Related articles

    3.

    Concomitant secretion of glucocorticoid, androgens, and mineralocorticoid by an adrenocortical carcinoma: case report and review of literature.

    Messer CK, Kirschenbaum A, New MI, Unger P, Gabrilove JL, Levine AC.

    Endocr Pract. 2007 Jul-Aug;13(4):408-12. Review.PMID: 17669719 [PubMed - indexed for MEDLINE]Related articles

    4.

    An analysis of current neutropenia therapies, including pegfilgrastim.

    Gabrilove JL.

    Clin Cornerstone. 2006;8 Suppl 5:S19-28. Review.PMID: 17379160 [PubMed - indexed for MEDLINE]Related articles

    5.

    Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

    Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA; IRIS Investigators.

    N Engl J Med. 2006 Dec 7;355(23):2408-17.PMID: 17151364 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Clinical benefits of epoetin alfa therapy in patients with lung cancer.

    Crawford J, Demetri GD, Gabrilove JL, Blasi MV, Sarokhan BJ, Glaspy J.

    Clin Lung Cancer. 2002 Feb;3(3):180-90.PMID: 14662041 [PubMed]Related articlesFree article

    7.

    Statistical explanations for a community-based study of once-weekly epoetin alfa therapy in patients receiving chemotherapy.

    Gabrilove JL, Sarokhan B, Cremieux P.

    J Clin Oncol. 2002 Jun 1;20(11):2757-8. No abstract available. PMID: 12039942 [PubMed - indexed for MEDLINE]Related articles

    8.

    Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy.

    Demetri GD, Gabrilove JL, Blasi MV, Hill RJ Jr, Glaspy J.

    Clin Breast Cancer. 2002 Apr;3(1):45-51.PMID: 12020395 [PubMed - indexed for MEDLINE]Related articles

    9.

    The pathogenesis of the polycystic ovary syndrome: a hypothesis.

    Gabrilove JL.

    Endocr Pract. 2002 Mar-Apr;8(2):127-32. Review. No abstract available. PMID: 11951826 [PubMed - indexed for MEDLINE]Related articles

    10.

    Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies.

    Gabrilove JL.

    Oncologist. 2001;6 Suppl 5:4-7. Review.PMID: 11700386 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hematologic malignancies: an opportunity for targeted drug therapy.

    Gabrilove JL.

    Oncologist. 2001;6 Suppl 5:1-3. Review. No abstract available. PMID: 11700385 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cancer therapy. New strategies and treatment modalities for optimizing patient outcomes.

    Gabrilove JL.

    Semin Hematol. 2001 Jul;38(3 Suppl 7):1-7. Review.PMID: 11523022 [PubMed - indexed for MEDLINE]Related articles

    13.

    A cluster of cases of factitious Cushing's syndrome.

    Villanueva RB, Brett E, Gabrilove JL.

    Endocr Pract. 2000 Mar-Apr;6(2):143-7.PMID: 11421530 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

    Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH.

    J Clin Oncol. 2001 Jun 1;19(11):2875-82.PMID: 11387360 [PubMed - indexed for MEDLINE]Related articles

    15.

    Serum granulocyte colony-stimulating factor levels are not increased in patients with autoimmune neutropenia of infancy.

    Corbacioglu S, Bux J, König A, Gabrilove JL, Welte K, Bussel JB.

    J Pediatr. 2000 Jul;137(1):96-9.PMID: 10891829 [PubMed - indexed for MEDLINE]Related articles

    16.

    Recurrent Cushing's syndrome due to recurrent adrenocortical tumor--fragmentation or tumor in ectopic adrenal tissue?

    Leibowitz J, Pertsemlidis D, Gabrilove JL.

    J Clin Endocrinol Metab. 1998 Nov;83(11):3786-9.PMID: 9814447 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner.

    Wang ZG, Rivi R, Delva L, König A, Scheinberg DA, Gambacorti-Passerini C, Gabrilove JL, Warrell RP Jr, Pandolfi PP.

    Blood. 1998 Sep 1;92(5):1497-504.PMID: 9716575 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Where you go depends on where you are. Early investigations on the use of deoxycorticosterone in Addison's disease: a historical vignette.

    Gabrilove JL, Simon BE.

    J Clin Endocrinol Metab. 1998 May;83(5):1428-30. No abstract available. PMID: 9589633 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Antitumor activity of actinonin in vitro and in vivo.

    Xu Y, Lai LT, Gabrilove JL, Scheinberg DA.

    Clin Cancer Res. 1998 Jan;4(1):171-6.PMID: 9516967 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines.

    König A, Schwartz GK, Mohammad RM, Al-Katib A, Gabrilove JL.

    Blood. 1997 Dec 1;90(11):4307-12.PMID: 9373241 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines.

    König A, Wrazel L, Warrell RP Jr, Rivi R, Pandolfi PP, Jakubowski A, Gabrilove JL.

    Blood. 1997 Jul 15;90(2):562-70.PMID: 9226155 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.

    König A, Menzel T, Lynen S, Wrazel L, Rosén A, Al-Katib A, Raveche E, Gabrilove JL.

    Leukemia. 1997 Feb;11(2):258-65.PMID: 9009090 [PubMed - indexed for MEDLINE]Related articles

    23.

    Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells.

    Wieder R, Wang H, Shirke S, Wang Q, Menzel T, Feirt N, Jakubowski AA, Gabrilove JL.

    Growth Factors. 1997;15(1):41-60.PMID: 9401817 [PubMed - indexed for MEDLINE]Related articles

    24.

    The role of sex steroids in the pathogenesis and maintenance of benign prostatic hyperplasia.

    Levine AC, Kirschenbaum A, Gabrilove JL.

    Mt Sinai J Med. 1997 Jan;64(1):20-5.PMID: 8997072 [PubMed - indexed for MEDLINE]Related articles

    25.

    Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth.

    Gabrilove JL, White K, Rahman Z, Wilson EL.

    Blood. 1994 Feb 15;83(4):907-10.PMID: 7509211 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Phase I trial of intravenous and intraperitoneal administration of granulocyte-macrophage colony-stimulating factor.

    Toner GC, Gabrilove JL, Gordon M, Crown J, Jakubowski AA, Meisenberg B, Sheridan C, Boone T, Vincent ME, Markman M.

    J Immunother Emphasis Tumor Immunol. 1994 Jan;15(1):59-66.PMID: 8110732 [PubMed - indexed for MEDLINE]Related articles

    27.

    Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells.

    Bruno E, Cooper RJ, Wilson EL, Gabrilove JL, Hoffman R.

    Blood. 1993 Jul 15;82(2):430-5.PMID: 8329701 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Cytokine treatment of inherited bone marrow failure syndromes.

    Gillio AP, Gabrilove JL.

    Blood. 1993 Apr 1;81(7):1669-74. Review. No abstract available. PMID: 8461458 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Interleukin-1 modulation of cytokine receptors on human neutrophils: in vitro and in vivo studies.

    Shieh JH, Gordon M, Jakubowski A, Peterson RH, Gabrilove JL, Moore MA.

    Blood. 1993 Apr 1;81(7):1745-54.PMID: 7681702 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.

    Seidman AD, Scher HI, Gabrilove JL, Bajorin DF, Motzer RJ, O'Dell M, Curley T, Dershaw DD, Quinlivan S, Tao Y, et al.

    J Clin Oncol. 1993 Mar;11(3):408-14.PMID: 7680373 [PubMed - indexed for MEDLINE]Related articles

    31.

    Basic fibroblast growth factor counteracts the suppressive effect of transforming growth factor-beta 1 on human myeloid progenitor cells.

    Gabrilove JL, Wong G, Bollenbacher E, White K, Kojima S, Wilson EL.

    Blood. 1993 Feb 15;81(4):909-15.PMID: 8427999 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Virilizing adrenocortical tumor superimposed on congenital adrenocortical hyperplasia.

    Shimshi M, Ross F, Goodman A, Gabrilove JL.

    Am J Med. 1992 Sep;93(3):338-42. Review.PMID: 1524088 [PubMed - indexed for MEDLINE]Related articles

    33.

    Cushing's syndrome.

    Gabrilove JL.

    Compr Ther. 1992 Aug;18(8):13-6. Review. No abstract available. PMID: 1424529 [PubMed - indexed for MEDLINE]Related articles

    34.

    Modulation of leukemic cell growth by tumor necrosis factor: action and expression in myeloid leukemia.

    Steffen M, Budde-Steffen C, Gabrilove JL, Moore MA.

    Leukemia. 1992 Jul;6(7):634-41.PMID: 1378161 [PubMed - indexed for MEDLINE]Related articles

    35.

    Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta.

    Hannocks MJ, Oliver L, Gabrilove JL, Wilson EL.

    Blood. 1992 Mar 1;79(5):1178-84.PMID: 1536945 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Re: Treatment of benign prostatic hypertrophy by a long-acting gonadotropin-releasing hormone analogue: 1-year experience.

    Gabrilove JL, Levine AC, Kirschenbaum A, Droller M.

    J Urol. 1992 Feb;147(2):474. No abstract available. PMID: 1370700 [PubMed - indexed for MEDLINE]Related articles

    37.

    Clinical applications of granulocyte colony stimulating factor (G-CSF).

    Gabrilove JL.

    Growth Factors. 1992;6(3):187-91. Review. No abstract available. PMID: 1382483 [PubMed - indexed for MEDLINE]Related articles

    38.

    Effect of the addition of estrogen to medical castration on prostatic size, symptoms, histology and serum prostate specific antigen in 4 men with benign prostatic hypertrophy.

    Levine AC, Kirschenbaum A, Droller M, Gabrilove JL.

    J Urol. 1991 Sep;146(3):790-3. Erratum in: J Urol 1992 Sep;148(3):898. PMID: 1714969 [PubMed - indexed for MEDLINE]Related articles

    39.

    Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures.

    Wilson EL, Rifkin DB, Kelly F, Hannocks MJ, Gabrilove JL.

    Blood. 1991 Mar 1;77(5):954-60.PMID: 1995102 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Colony-stimulating factors: clinical status.

    Gabrilove JL.

    Important Adv Oncol. 1991:215-37. Review. No abstract available. PMID: 1714420 [PubMed - indexed for MEDLINE]Related articles

    41.

    Novel retinoic acid receptor-alpha transcripts in acute promyelocytic leukemia responsive to all-trans-retinoic acid.

    Miller WH Jr, Warrell RP Jr, Frankel SR, Jakubowski A, Gabrilove JL, Muindi J, Dmitrovsky E.

    J Natl Cancer Inst. 1990 Dec 19;82(24):1932-3. No abstract available. PMID: 2174466 [PubMed - indexed for MEDLINE]Related articles

    42.

    Colony-stimulating factors.

    Gordon MS, Gabrilove JL.

    Curr Opin Oncol. 1990 Dec;2(6):1152-8. Review. No abstract available. PMID: 1712236 [PubMed - indexed for MEDLINE]Related articles

    43.

    Ketoconazole use in the treatment of ovarian hyperandrogenism.

    Pepper G, Brenner SH, Gabrilove JL.

    Fertil Steril. 1990 Sep;54(3):438-44.PMID: 2168844 [PubMed - indexed for MEDLINE]Related articles

    44.

    Biological effects and clinical applications of human colony-stimulating factors.

    Gabrilove JL, Jakubowski A.

    Cancer Chemother Biol Response Modif. 1990;11:631-62. Review. No abstract available. PMID: 2223409 [PubMed - indexed for MEDLINE]Related articles

    45.

    Biology and clinical applications of human recombinant granulocyte colony-stimulating factor.

    Gabrilove JL.

    Cancer Invest. 1990;8(2):295-7. No abstract available. PMID: 1698112 [PubMed - indexed for MEDLINE]Related articles

    46.

    Hematopoietic growth factors: biology and clinical application.

    Gabrilove JL, Jakubowski A.

    J Natl Cancer Inst Monogr. 1990;(10):73-7. Review.PMID: 1693284 [PubMed - indexed for MEDLINE]Related articles

    47.

    Granulocyte colony-stimulating factor: preclinical and clinical studies.

    Gabrilove JL, Jakubowski A.

    Hematol Oncol Clin North Am. 1989 Sep;3(3):427-40. Review.PMID: 2483722 [PubMed - indexed for MEDLINE]Related articles

    48.

    Effect of long-acting gonadotropin-releasing hormone analog (leuprolide) therapy on prostatic size and symptoms in 15 men with benign prostatic hypertrophy.

    Gabrilove JL, Levine AC, Kirschenbaum A, Droller M.

    J Clin Endocrinol Metab. 1989 Sep;69(3):629-32.PMID: 2474565 [PubMed - indexed for MEDLINE]Related articles

    49.

    Serum prostate-antigen levels in patients with benign prostatic hypertrophy treated with leuprolide.

    Levine AC, Kirschenbaum A, Kaplan P, Droller MA, Gabrilove JL.

    Urology. 1989 Jul;34(1):10-3.PMID: 2473567 [PubMed - indexed for MEDLINE]Related articles

    50.

    Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis.

    Bonilla MA, Gillio AP, Ruggeiro M, Kernan NA, Brochstein JA, Abboud M, Fumagalli L, Vincent M, Gabrilove JL, Welte K, et al.

    N Engl J Med. 1989 Jun 15;320(24):1574-80.PMID: 2471075 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...